annual meeting program - American Society of Clinical Oncology

Monday, June 7, 2010
5:15 PM Gemcitabine plus erlotinib (GE) followed by capecitabine (C) versus
capecitabine plus erlotinib (CE) followed by gemcitabine (G) in advanced
pancreatic cancer (APC): A randomized, cross-over phase III trial of the
Arbeitsgemeinschaft Internistische Onkologie (AIO). (Abstract #LBA4011)
S. H. Boeck, U. Vehling-Kaiser, D. Waldschmidt, E. Kettner, A. Märten, C.
Winkelmann, S. Klein, G. Kojouharoff, A. Jung, V. Heinemann
5:30 PM CapRI: Final results of the open-label, multicenter, randomized phase III trial
of adjuvant chemoradiation plus interferon-�-2b (CRl) versus 5-FU alone for
patients with resected pancreatic adenocarcinoma (PAC). (Abstract
#LBA4012)
A. Marten, J. Schmidt, J. Debus, S. Harig, K. Lindel, J. Klein, D. K. Bartsch,
L. Capussotti, C. Zülke, M. Buchler
Discussion
5:45 PM Margaret A. Tempero, MD (Abstracts #4010–LBA4012)
University of California, San Francisco
409
MONDAY